SOUTH SAN FRANCISCO, Calif. (AP) _ Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported a loss of $15.6 million in its fourth quarter.
The South San Francisco, California-based company said it had a loss of 16 cents per share.
The drug developer posted revenue of $3 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $4.9 million.
For the year, the company reported that its loss widened to $69.2 million, or 73 cents per share. Revenue was reported as $20.4 million.
In the final minutes of trading on Tuesday, the company's shares hit $2.61. A year ago, they were trading at $2.52.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL
Keywords: Rigel Pharmaceuticals, Earnings Report